These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


236 related items for PubMed ID: 8391429

  • 1. Low concentrations of dopamine increase cytosolic calcium in lactotrophs.
    Burris TP, Freeman ME.
    Endocrinology; 1993 Jul; 133(1):63-8. PubMed ID: 8391429
    [Abstract] [Full Text] [Related]

  • 2. Neuropeptide Y suppresses prolactin secretion from rat anterior pituitary cells: evidence for interactions with dopamine through inhibitory coupling to calcium entry.
    Wang J, Ciofi P, Crowley WR.
    Endocrinology; 1996 Feb; 137(2):587-94. PubMed ID: 8593806
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the forms of the dopamine D2 receptor expressed in GH4C1 cells.
    Burris TP, Freeman ME.
    Proc Soc Exp Biol Med; 1994 Mar; 205(3):226-35. PubMed ID: 8171043
    [Abstract] [Full Text] [Related]

  • 4. The stimulatory and inhibitory effects of dopamine on prolactin secretion involve different G-proteins.
    Burris TP, Nguyen DN, Smith SG, Freeman ME.
    Endocrinology; 1992 Feb; 130(2):926-32. PubMed ID: 1733734
    [Abstract] [Full Text] [Related]

  • 5. Single cell monitoring of cytosolic calcium reveals subtypes of rat lactotrophs with distinct responses to dopamine and thyrotropin-releasing hormone.
    Winiger BP, Wuarin F, Zahnd GR, Wollheim CB, Schlegel W.
    Endocrinology; 1987 Dec; 121(6):2222-8. PubMed ID: 3119314
    [Abstract] [Full Text] [Related]

  • 6. Effect of dopamine withdrawal on activation of adenylate cyclase and phospholipase C in enriched lactotrophs.
    Martinez de la Escalera G, Weiner RI.
    Endocrinology; 1988 Sep; 123(3):1682-7. PubMed ID: 2456918
    [Abstract] [Full Text] [Related]

  • 7. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
    Christian HC, Chapman LP, Morris JF.
    J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
    [Abstract] [Full Text] [Related]

  • 8. Pharmacologic evidence that a D2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland.
    Burris TP, Stringer LC, Freeman ME.
    Neuroendocrinology; 1991 Aug; 54(2):175-83. PubMed ID: 1685014
    [Abstract] [Full Text] [Related]

  • 9. Effects of withdrawal of dopamine on translocation of protein kinase C isozymes and prolactin secretion in rat lactotroph-enriched pituitary cells. Modulation of substance P-mediated responses.
    Mau SE.
    J Mol Endocrinol; 1997 Jun; 18(3):181-91. PubMed ID: 9195472
    [Abstract] [Full Text] [Related]

  • 10. Dopamine withdrawal elicits prolonged calcium rise to support prolactin rebound release.
    Ho MY, Kao JP, Gregerson KA.
    Endocrinology; 1996 Aug; 137(8):3513-21. PubMed ID: 8754781
    [Abstract] [Full Text] [Related]

  • 11. Calcium/calmodulin-dependent protein kinase-II activation in rat pituitary cells in the presence of thyrotropin-releasing hormone and dopamine.
    Cui ZJ, Gorelick FS, Dannies PS.
    Endocrinology; 1994 May; 134(5):2245-50. PubMed ID: 8156928
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of the inhibitory action of dopamine and somatostatin on prolactin secretion from human lactotrophs in culture.
    Ishibashi M, Yamaji T.
    J Clin Endocrinol Metab; 1985 Mar; 60(3):599-606. PubMed ID: 2579087
    [Abstract] [Full Text] [Related]

  • 13. Stimulation of the adenosine 3',5'-monophosphate and the Ca2+ messenger systems together reverse dopaminergic inhibition of prolactin release.
    Delbeke D, Dannies PS.
    Endocrinology; 1985 Aug; 117(2):439-46. PubMed ID: 2990850
    [Abstract] [Full Text] [Related]

  • 14. Arachidonic acid increases cytosolic calcium and stimulates hormone release in rat lactotrophs.
    Roudbaraki MM, Vacher P, Drouhault R.
    Am J Physiol; 1995 Jun; 268(6 Pt 1):E1215-23. PubMed ID: 7611398
    [Abstract] [Full Text] [Related]

  • 15. TRH raises cytosolic Ca2+ in human adenomatous lactotrophs.
    Spada A, Reza-Elahi F, Lania A.
    J Endocrinol Invest; 1990 Jan; 13(1):13-8. PubMed ID: 2108197
    [Abstract] [Full Text] [Related]

  • 16. Paradoxical effects of dopamine (DA): Gi alpha 3 mediates DA inhibition of PRL release while masking its PRL-releasing activity.
    Kineman RD, Gettys TW, Frawley LS.
    Endocrinology; 1994 Aug; 135(2):790-3. PubMed ID: 8033828
    [Abstract] [Full Text] [Related]

  • 17. Somatostatin inhibits prolactin secretion by multiple mechanisms involving a site of action distal to increased cyclic adenosine 3',5'-monophosphate and elevated cytosolic Ca2+ in rat lactotrophs.
    Bjøro T, Ostberg BC, Sand O, Torjesen PA, Penman E, Gordeladze JO, Iversen JG, Gautvik KM, Haug E.
    Acta Physiol Scand; 1988 Jul; 133(3):271-82. PubMed ID: 2906508
    [Abstract] [Full Text] [Related]

  • 18. Dihydropyridine-sensitive calcium channel activity related to prolactin, growth hormone, and luteinizing hormone release from anterior pituitary cells in culture: interactions with somatostatin, dopamine, and estrogens.
    Drouva SV, Rerat E, Bihoreau C, Laplante E, Rasolonjanahary R, Clauser H, Kordon C.
    Endocrinology; 1988 Dec; 123(6):2762-73. PubMed ID: 2461851
    [Abstract] [Full Text] [Related]

  • 19. Role of guanine nucleotide-binding proteins, Gi alpha 3 and Gs alpha, in dopamine and thyrotropin-releasing hormone signal transduction: evidence for competition and commonality.
    Kineman RD, Gettys TW, Frawley LS.
    J Endocrinol; 1996 Mar; 148(3):447-55. PubMed ID: 8778223
    [Abstract] [Full Text] [Related]

  • 20. The cortical actin cytoskeleton of lactotropes as an intracellular target for the control of prolactin secretion.
    Carbajal ME, Vitale ML.
    Endocrinology; 1997 Dec; 138(12):5374-84. PubMed ID: 9389523
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.